Based only on the facts in our directory. The right pick still depends on the job you need done.
Lower starting price
Not comparable
Not comparable: Immunai does not list a price
Free plan
Tie
Neither has one
Higher rating
Tie
4.0 against 4.0
Same job?
Yes
Both are Healthcare AI tools
Side by side
Compared on
Immunai
Zephyr AI
Our rating
4.0
4.0
Starts at
Not listed
Not listed
Free plan
No
No
Category
Healthcare AI
Healthcare AI
Plans
See pricing
See pricing
Key features
AMICA-OS platform built on single-cell multi-omic immune system data
Target discovery tools for identifying new drug candidates from immune cell behavior
Preclinical evaluation modeling for testing target hypotheses before trials
Clinical trial optimization using immune-response data
One of the industry's largest clinical immunology datasets, built through 30-plus pharma partnerships
Multi-modal real-world data integration
Interpretable machine learning models
Discovery, validation and deployment coverage
Enterprise-scale data processing
Fits existing workflows with no new assays required
Pros
Dataset scale, built through partnerships with Fortune 100 pharma companies, gives its models depth smaller labs can't replicate
Covers the full pipeline from target discovery through clinical trial optimization rather than one narrow step
Named partnerships with AstraZeneca, Boehringer Ingelheim, Pfizer, and Novo Nordisk demonstrate real commercial traction
Interpretable models, which is what makes a target hypothesis actionable
Works on data already generated rather than requiring new collection
Covers the therapeutic lifecycle rather than one stage
Cons
No published pricing; every engagement is a custom partnership negotiation
Built exclusively for pharmaceutical R&D, inaccessible to academic labs or individual researchers without a deal
Value depends on data-sharing arrangements with partners, which take time to negotiate and set up
No published pricing, contact only
Real-world data carries the biases of who received care and where
Findings need prospective validation before changing clinical decisions
Company
Immunai, founded 2018
Zephyr AI
Prices come from each vendor's pricing page, last checked 20260814. Check the vendor before you buy.
FAQ
Questions people ask
Is Immunai better than Zephyr AI?
In our reviews Immunai scores 4.0 and Zephyr AI scores 4.0. The better pick depends on the job. Immunai: AI platform mapping the human immune system at single-cell resolution to accelerate drug discovery for pharma partners. Zephyr AI: Precision medicine from real-world data, with interpretable models and no new assays.
Immunai
Zephyr AI
